NBE-Therapeutics Appoints Erich Schlick as Chairman of the Board of Directors |
| August 10, 2020 | August 2020 Bond Updates |
|
BASEL, Switzerland, Aug. 10, 2020 /PRNewswire/ -- NBE-Therapeutics, the Swiss-based company developing best-in- class cancer therapies based on its proprietary, highly differentiated Antibody Drug Conjugate (ADC) platform, announces the appointment of Prof. Dr. Erich Schlick as... |
| View more at: https://www.prnewswire.com:443/news-releases/nbe-therapeutics-appoints-erich-schlick-as-chairman-of-the-board-of-directors-301108800.html |
| Related News |
|